Combined with knowledge of decreased IL-1β production, smaller infarct volumes, and improved functional outcome, this information helps to understand how BM cells promote neuroprotection after tMCAo in mice, a potential future stroke therapy. The gene discussed is IL1B; the disease is Stroke.